Data exports

April 2021

6 Insights

6 Insights

Since our last feature on data exports in October 2020, we've seen significant developments including the EU's new draft standard contractual clauses, draft UK adequacy agreements and guidance on applying the Schrems II judgment. We also look at the impact of data export rules on clinical trial data, data exports from Asia, and data transfers in the context of M&A deals.

Data transfers – will Asia lead the way?

Jo Joyce looks at the development of data transfer laws in Asia, focusing on six major jurisdictions.

More
Click here to find out more

Dealing with cross-border transfers and other data protection issues in M&A deals

Chris Jeffery looks at data transfers and other issues in the context of M&A deals.

More
Click here to find out more

EDPB guidance on data transfers to third countries in wake of Schrems II

Debbie Heywood looks at the EDPB recommendations on supplementing data transfer tools to help protect personal data exported to third countries.

More
Click here to find out more

How to keep clinical trial data flowing under GDPR and after Brexit

Debbie Heywood looks at cross-border transfers of clinical trial data in the UK and the EU.

More
Click here to find out more

Path paved for EU-UK adequacy decisions

More
Click here to find out more

The new draft Standard Contractual Clauses – legal certainty for data transfers?

Paul Voigt looks at the pros and cons of the new draft SCCs.

More
Click here to find out more

Back to

Global Data Hub

Go to Global Data Hub main hub